Comparative oncology seeks to investigate cancer diagnostics, treatments and prevention in all species in hopes that new technologies and treatments can be developed faster and translated into both the veterinary care of companion animals as well as preliminary data that can inform human clinical trials....
At Alumni Park, University of Wisconsin–Madison students past, present and future stop to take pictures of the lines radiating from a Numen Lumen seal set into the sidewalk. One line notes the exact distance — 9,181 miles — from Madison to the South Pole, where UW...
UW Carbone Cancer Center patient Gary Davey struggled with metastatic prostate cancer until a clinical trial brought new hope....
The Blue Ridge Institute for Medical Research (BRIMR) has listed the University of Wisconsin Department of Medicine as 12th in the nation for departments of internal medicine receiving research funding from the National Institutes of Health (NIH) in 2023....
The ongoing effort to make Wisconsin a nationally recognized technology hub could get a $7.5 million boost from state funds following the passage of a bill designed to help Wisconsin compete for up to $70 million in federal funds. ...
At the Universities of Wisconsin Board of Regents meeting on Friday, Feb. 9, experts gathered to discuss the university’s strategy for maximizing federal funding through burgeoning public-private partnerships, a crucial component of the national push for innovation and economic development....
The University of Wisconsin—Madison will build on its 175 years of excellence with several bold new initiatives designed to address global challenges, notably artificial intelligence and environmental sustainability....
Robert N. Golden, who has served as dean of the University of Wisconsin School of Medicine and Public Health (SMPH) since 2006, announced today that he will be stepping down as dean and vice chancellor for medical affairs once a successor is in place....
Lupus significantly and disproportionately impacts Black, Hispanic and Asian patients, but these populations are underrepresented in clinical trials for the disease....
The five-year study will provide state-of-the-art imaging and blood-based biomarkers for researchers around the world to study and advance the field of Alzheimer’s and related dementias. The work is also designed to shed light on mixed dementia, where more than one neurological disease is contributing...
